These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 29212930)

  • 21. Human T-cell leukemia virus type 1 envelope glycoprotein gp46 interacts with cell surface heparan sulfate proteoglycans.
    Piñon JD; Klasse PJ; Jassal SR; Welson S; Weber J; Brighty DW; Sattentau QJ
    J Virol; 2003 Sep; 77(18):9922-30. PubMed ID: 12941902
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development of an infectious surrogate hepatitis C virus based on a recombinant vesicular stomatitis virus expressing hepatitis C virus envelope glycoproteins and green fluorescent protein.
    Okuma K; Fukagawa K; Tateyama S; Kohma T; Mochida K; Hiyoshi M; Takahama Y; Hamaguchi Y; Hirose K; Buonocore L; Rose JK; Mizuochi T; Hamaguchi I
    Jpn J Infect Dis; 2015; 68(3):203-8. PubMed ID: 25672345
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A Unique T-Cell Receptor Amino Acid Sequence Selected by Human T-Cell Lymphotropic Virus Type 1 Tax
    Ishihara Y; Tanaka Y; Kobayashi S; Kawamura K; Nakasone H; Gomyo A; Hayakawa J; Tamaki M; Akahoshi Y; Harada N; Kusuda M; Kameda K; Ugai T; Wada H; Sakamoto K; Sato M; Terasako-Saito K; Kikuchi M; Kimura SI; Tanihara A; Kako S; Uchimaru K; Kanda Y
    J Virol; 2017 Oct; 91(19):. PubMed ID: 28724766
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluating replication-defective vesicular stomatitis virus as a vaccine vehicle.
    Majid AM; Ezelle H; Shah S; Barber GN
    J Virol; 2006 Jul; 80(14):6993-7008. PubMed ID: 16809305
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mapping of immunogenic regions of human T cell leukemia virus type I (HTLV-I) gp46 and gp21 envelope glycoproteins with env-encoded synthetic peptides and a monoclonal antibody to gp46.
    Palker TJ; Tanner ME; Scearce RM; Streilein RD; Clark ME; Haynes BF
    J Immunol; 1989 Feb; 142(3):971-8. PubMed ID: 2563272
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tropical spastic paraparesis and HTLV-1 associated myelopathy: clinical, epidemiological, virological and therapeutic aspects.
    Gessain A; Mahieux R
    Rev Neurol (Paris); 2012 Mar; 168(3):257-69. PubMed ID: 22405461
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A novel therapeutic molecule against HTLV-1 infection targeting provirus.
    Tanaka A; Takeda S; Kariya R; Matsuda K; Urano E; Okada S; Komano J
    Leukemia; 2013 Aug; 27(8):1621-7. PubMed ID: 23411465
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cellular Factors Involved in HTLV-1 Entry and Pathogenicit.
    Hoshino H
    Front Microbiol; 2012; 3():222. PubMed ID: 22737146
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Envelope proteins of human T-cell leukemia virus: expression in Escherichia coli and its application to studies of env gene functions.
    Kiyokawa T; Yoshikura H; Hattori S; Seiki M; Yoshida M
    Proc Natl Acad Sci U S A; 1984 Oct; 81(19):6202-6. PubMed ID: 6091139
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The N93D mutation of the human T-cell leukemia virus type 1 envelope glycoprotein found in symptomatic patients enhances neuropilin-1 b1 domain binding.
    Kusunoki H; Tanaka T; Ohshima C; Sakamoto T; Wakamatsu K; Hamaguchi I
    Biochim Biophys Acta Proteins Proteom; 2021 Nov; 1869(11):140708. PubMed ID: 34343702
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sequence analysis of an immunogenic and neutralizing domain of the human T-cell lymphoma/leukemia virus type I gp46 surface membrane protein among various primate T-cell lymphoma/leukemia virus isolates including those from a patient with both HTLV-I-associated myelopathy and adult T-cell leukemia.
    Sherman MP; Dube S; Spicer TP; Kane TD; Love JL; Saksena NK; Iannone R; Gibbs CJ; Yanagihara R; Dube DK
    Cancer Res; 1993 Dec; 53(24):6067-73. PubMed ID: 8261424
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular aspects of HTLV-1 entry: functional domains of the HTLV-1 surface subunit (SU) and their relationships to the entry receptors.
    Jones KS; Lambert S; Bouttier M; Bénit L; Ruscetti FW; Hermine O; Pique C
    Viruses; 2011 Jun; 3(6):794-810. PubMed ID: 21994754
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Host range of human T-cell leukemia virus type I analyzed by a cell fusion-dependent reporter gene activation assay.
    Okuma K; Nakamura M; Nakano S; Niho Y; Matsuura Y
    Virology; 1999 Feb; 254(2):235-44. PubMed ID: 9986790
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An animal model of adult T-cell leukemia: humanized mice with HTLV-1-specific immunity.
    Tezuka K; Xun R; Tei M; Ueno T; Tanaka M; Takenouchi N; Fujisawa J
    Blood; 2014 Jan; 123(3):346-55. PubMed ID: 24196073
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of the recombinant vaccinia viruses that express HTLV-I envelope gene on HTLV-I infection.
    Shida H; Tochikura T; Sato T; Konno T; Hirayoshi K; Seki M; Ito Y; Hatanaka M; Hinuma Y; Sugimoto M
    EMBO J; 1987 Nov; 6(11):3379-84. PubMed ID: 2828027
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vivo analysis of replication and immunogenicity of proviral clones of human T-lymphotropic virus type 1 with selective envelope surface-unit mutations.
    Silverman LR; Phipps AJ; Montgomery A; Fernandez S; Tsukahara T; Ratner L; Lairmore MD
    Blood; 2005 Nov; 106(10):3602-8. PubMed ID: 16046523
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Targeting aberrant DNA hypermethylation as a driver of ATL leukemogenesis by using the new oral demethylating agent OR-2100.
    Watanabe T; Yamashita S; Ureshino H; Kamachi K; Kurahashi Y; Fukuda-Kurahashi Y; Yoshida N; Hattori N; Nakamura H; Sato A; Kawaguchi A; Sueoka-Aragane N; Kojima K; Okada S; Ushijima T; Kimura S; Sueoka E
    Blood; 2020 Aug; 136(7):871-884. PubMed ID: 32391874
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment of adult T-cell leukaemia/lymphoma: is the virus a target?
    Cook LB; Taylor GP
    Curr Opin Infect Dis; 2015 Dec; 28(6):583-8. PubMed ID: 26381999
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression of human immunodeficiency virus type 1 Gag protein precursor and envelope proteins from a vesicular stomatitis virus recombinant: high-level production of virus-like particles containing HIV envelope.
    Haglund K; Forman J; Kräusslich HG; Rose JK
    Virology; 2000 Mar; 268(1):112-21. PubMed ID: 10683333
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of a recombinant HTLV-II envelope protein for serological detection of HTLV-II carriers.
    Chen YM; Essex M
    AIDS Res Hum Retroviruses; 1991 May; 7(5):453-7. PubMed ID: 1873080
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.